医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

MADISON, Wis.

Promega Corporation announces the launch of GloMax® Explorer Multimode Detection System, a flexible multimode reader for luminescence, fluorescence and absorbance detection integrated with over 50 optimized, preloaded Promega protocols to address a variety of research needs.

Integrated with Over 50 Preloaded Protocols, Promega GloMax(R) Explorer Multimode Detection System allows researchers to choose the components needed for their current work and upgrade as experimental needs grow. (Photo: Business Wire)

The GloMax Explorer System is designed with preloaded Promega protocols to minimize time spent optimizing instrument settings. Complemented by the wide range of integrated Promega assays, including nucleic acid quantitation for next-generation sequencing, GloMax Explorer provides high sensitivity, a broad dynamic range and low well-to-well cross talk that generate more usable and relevant data. Users also have the option of customizing their own protocols in accordance with specific needs.

As the newest member of the GloMax® System detection instruments, GloMax Explorer allows researchers to choose a range of detection modules for their current work and upgrade capabilities as their experimental needs grow. Multiplexed cell viability, apoptosis and cytotoxicity assays are easily performed with minimal manual intervention because of automated filter switching. The software is SiLA compatible, making integration of device control simple.

Using the instrument’s touchscreen display and automatic gain adjustments, researchers can quickly generate and analyze data from critical experiments with minimal set-up time and effort. From the touchscreen, users can set up a plate map, view data in a heat map display and easily export their results to a variety of locations without complicated adjustments.

To learn more about the GloMax Explorer Multimode Detection System, visit: www.promega.com/GloMax

Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 3,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, drug discovery and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 16 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150430005060/en/